Assist
Where required, assists with the provision of analytical services, also ensures that proper disposal requirements are prescribed for the safe disposal of cannabis which is handled under the Act.
Learn MoreWhat are the functions of the BMCLA?
Develop
Develop policies, procedures and guidelines to establish the medicinal cannabis industry and to ensure that medicinal cannabis is available to patients in a safe and efficient manner.
Learn MoreProvide
Issues licences in relation to the handling of medicinal cannabis in accordance with the provisions of the Act, 2019, also provides for the distribution of educational materials etc.
Learn MoreRegulate
Regulates the handling of medicinal cannabis, with the approval of the Barbados Medicinal Cannabis Licensing Board, establishes and maintains an electronic database.
Learn MoreOur Latest News & Opportunities
From Our Community
Get the latest top news stories and updates from BMCLA and the Medicinal Cannabis Community. Find videos, articles and downloads on the latest top news stories in the region.
Frequently Asked Questions
Who can dispense Medicinal Cannabis?
A pharmacist or authorized personnel in a pharmacy or a therapeutic facility may dispense medicinal cannabis to a patient and where applicable, to a caregiver for a patient. A pharmacist or authorized personnel in a pharmacy should only dispense medicinal cannabis on the submission by a patient, or where applicable, a caregiver, of a prescription and a valid form of identification for the patient. Upon dispensing medicinal cannabis to a patient or, where applicable, a caregiver, a pharmacist should ensure that the label given in respect of the prescription has the information required by regulations of the Pharmacy (compounding and Dispensing of Drugs and Poisons) Regulations, 1986. A pharmacist shall enter the information of the patient in a register kept by him or her and established for the purpose, in the prescribed manner:
-
Conform to any requirement or limitation set by the medical practitioner as to the form of medicinal cannabis that is required in relation to the patient;
-
Provide to a patient and where applicable, a caregiver, information on the lawful methods for administering medicinal cannabis in individual doses;
-
Provide to a patient and where applicable, a caregiver, information on how to prevent or deter the misuse of medicinal cannabis by a minor; or
-
Provide to a patient, and where applicable, a caregiver, any other information which the pharmacist may consider to be relevant.
I’m a Patient how do I access Medicinal Cannabis?
11. How do you get medicinal cannabis?
A patient can only get access to medicinal cannabis as a prescription by a medical practitioner.
That prescription can only be filled by a pharmacist or authorised personnel in a pharmacy or therapeutic facility.
A pharmacist or authorised personnel in a pharmacy shall only dispense or supply medicinal cannabis on the submission by a patient or where applicable, a caregiver, of a prescription and a valid form of identification.
Upon dispensing medicinal cannabis to a patient (or, where applicable, a caregiver), a pharmacist or authorised personnel shall ensure that the label given in respect of the prescription has the information required by Pharmacy (Compounding and Dispensing of Drugs and Poisons) Regulations, 1986.
A pharmacist shall enter the information in a register kept by him/her and established for that purpose, in the prescribed manner.
A person who consumes medicinal cannabis without being authorised to use medicinal cannabis by a prescription or recommendation from a medical practitioner is guilty of an offence and is liable on conviction on indictment to a fine of $100 000 or to imprisonment for a term of 10 years or to both.
12. How is medicinal cannabis administered?
Medical cannabis can be administered by a variety of formulations which may include vapours, tinctures, oromucosal sprays, oral forms, transdermal patches, ointments and suppositories.
13. Will there be rigorous testing done to medicinal cannabis?
The BMCLA in conjunction with accredited testing laboratories will facilitate the testing of medicinal cannabis to ensure the products meet safety and efficacy requirements.
14. Will there be clear guidelines for prescribing medicinal cannabis for the use of patients or will doctors be left to experiment?
The BMCLA and its Board, are responsible for regulating the medicinal cannabis industry, through the formulation and implementation of appropriate policies, procedures and guidelines, as well as establishing the code of practice for practitioners in the industry. We work closely with the Ministry of Health and Wellness via its regulatory bodies such as the Barbados Drug Service to ensure safe and evidence-based treatment options for patients. Currently, there are five legally-approved medicinal cannabis drugs, placed on the National Drug Formulary. Patients can access these drugs under the provisions of Section 12 of the Drug Abuse (Prevention and Control) Act Cap 131.
15. Are there dose limitations?
In circumstances where a prescription by a medical practitioner requires repeated usage over a period of 3 months, a pharmacy or therapeutic facility shall not dispense to that patient more than 30-day supply of individual does at a time.
Minors and Medicinal cannabis
16. Can a minor be prescribed medicinal cannabis?
According to the Barbados Medicinal Cannabis Industry Act, 2019 the parent or guardian of a patient who is a minor shall obtain a certificate in writing from a medical practitioner certifying that the use of medicinal cannabis is necessary in the case of that minor, and the parent or guardian shall consent in writing to the use of medicinal cannabis for the treatment of the minor.
The Act also states that a parent or legal guardian of a patient who is a minor shall be deemed to be the caregiver for that minor unless that parent or legal guardian designates another person, or a person is designated by an order of the Court.
Any person who is under the age of 18 years shall not be designated as a caregiver.
17. How will sale of medicinal cannabis to minors be addressed, particularly in light of those studies that suggest adolescents and pre-adolescents are more susceptible to negative psychological and medical consequences from using cannabis?
There will be no sale of medicinal cannabis to minors. Possession of cannabis on or near school premises, the inclusion of a child or young person in the drug trade and the purchase of cannabis from a child or young person is illegal and on indictment could result in imprisonment for life (Drug Abuse (Prevention and Control) Act Chapter 131).
A parent or guardian of a patient who is a minor or young person can access medicinal cannabis via mechanisms described above. However, a person who is under the age of 18 years shall not be designated as a caregiver of a minor or young person.
Important Note:Cannabis affects the same biological system in the brain that is responsible for brain development. The earlier you start consuming cannabis, the more harm it can do. Starting as a teen, consuming frequently (daily or near daily) and over a long time (several months or years) increases the risk of mental health problems. These problems include dependence and disorders related to psychosis, anxiety and depression. [1] For more information, visit your doctor.
[1] Chadwick B, Miller ML, Hurd YL. Cannabis use during adolescent development: Susceptibility to psychiatric illness. Front Psychiatry 2013 Oct 14;4:129.
What are the long-term effects of cannabis use?
Using cannabis frequently (daily or almost daily) and over a long time (several months or years) can[1]:
- Hurt your lungs and make it harder to breathe, if smoked
- Cannabis smoke may contain many of the same harmful chemicals found in tobacco smoke
- Affect your mental health
- Frequent use of THC based products over a long time increases the risk of cannabis dependence
- Increased risk of developing psychotic disorders
- Early exposure of cannabis use during the adolescent years can impair brain development and functioning
- Increased risk of cardiovascular disease
[1] Weinstein, AM, Cohen, K. Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review from Public Health Prospective. Frontiers in Public Health 2018; 6:1-8. doi: 10.3389/fpubh.2018.00162.
Prohibition against supply of medicinal cannabis
Prohibition against supply of medicinal cannabis A person shall not cultivate, supply, possess, or obtain medicinal cannabis for any of the purposes specified under the Act, unless that person is the holder of the relevant licenses issued pursuant to the Act. A person who cultivates, supplies, possesses, transports or obtains medicinal cannabis for any of the purposes specified under the Act without a relevant license is guilty of an offence and is liable on conviction on indictment, of a fine of 15 times the value of the medicinal cannabis cultivated, supplied, possessed, or obtained or to imprisonment for a term of 10 years, or to both.
How will side effects be dealt with as they are noted by the medical community?
Like any other prescribed medication, the administration of prescribed medicinal cannabis will be under supervision and monitoring by your doctor so to minimise harm, or negative interact to a patient. Factors like medical history, allergies, pregnancy, breastfeeding, co-morbidities, other medications that a patient may be taking will all be taken into consideration along with regular checkups.